Functional Imaging of Cognitive Psychopharmacology

Human Brain Function: Second Edition

Volumn , Issue , 2003, Pages 303-327

  Coull, J ^a   Thiele, C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 10044266926     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012264841-0/50018-4     Document Type: Chapter

References (153)

1. Abi-Dargham A., Mawlawi O., Lombardo I., Gil R., Martinez D., Huang Y., Hwang D.-R., Keilp J., Kochan L., van Heertum R., Gorman J., Laruelle M. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J.Neurosci. 2002, 22:3708-3719.
2. Altman H.J., Normile H.J. What is the nature of the role of the serotonergic nervous system in learning and memory: prospects for development of an effective treatment strategy for senile dementia. Neurobiol. Aging 1988, 9:627-638.
3. Amalric M., Koob G.F. Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in rats. J. Neurosci. 1987, 7:2129-2134.
4. Anderson I.M., Clark L., Elliott R., Kulkarni B., Williams S.R., Deakin J.F.W. 5-HT2 receptor activation by m-chlorophenylpiperazine detected in humans with fMRI. NeuroReport 2002, 13:1547-1551.
5. Arnsten A.F.T. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn. Sci. 1998, 2:436-447.
6. Arnsten A.F.T., Goldman-Rakic P.S. Alpha-2 adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science 1985, 230:1273-1276.
7. Arnsten A.F.T., Steere J.C., Hunt R.D. The contribution of a2-noradrenergic mechanisms to prefrontal cortical cognitive function: potential significance for attention-deficit hyperactivity disorder. Arch. Gen. Psychol. 1996, 5:448-455.
8. Ashe J.H., McKenna T.M., Weinberger N.M Cholinergic modulation of frequency receptive fields in auditory cortex. II. Frequency-specific effects of anticholinesterases provide evidence for a modulatory action of endogenous ACh. Synapse 1989, 4:44-54.
9. Aston-Jones G., Rajkowski J., Kubiak P., Alexinsky T. Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task. J. Neurosci. 1994, 14:4467-4480.
10. Avery R.A., Franowicz J.S., Studholme C., van Dyck C.H., Arnsten A.F.T. The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task. Neuropsychopharmacology 2000, 23:240-249.
11. Bagary M., Fluck E., File S.E., Joyce E., Lockwood G., Grasby P. Is benzodiazepine-induced amnesia due to deactivation of the left prefrontal cortex?. Psychopharmacology 2000, 150:292-299.
12. Barbee J.G. Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives. J. Clin. Psychiatry 1993, 54:86-97. (suppl.).
13. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38:1083-1152.
14. Beckers T., Wagemans J., Boucart M., Giersch A. Different effects of lorazepam and diazepam on perceptual integration. Vision Res. 2001, 41:2297-2303.
15. Bentley P., Vuilleumier P., Thiel C.M., Driver J., Dolan R.J. Effects of attention and emotion on face repetition, priming and their, modulation by cholinergic enhancement. J. Neurophysiol. 2003, 90:1171-1181.
16. Berger T.W., Weikart C.L., Bassett J.L., Orr W.B. Lesions of the retrosplenial cortex produce deficits in reversal learning of the rabbit nictitating membrane response: implications for potential interactions between hippocampal and cerebellar brain systems. Behav. Neurosci. 1986, 100:802-809.
17. Blokland A. Acetylcholine: a neurotransmitter for learning and memory?. Brain Res. Rev. 1996, 21:285-300.
18. Brooks D.J. PET studies and motor complications in Parkinson's disease. Trends Neurosci. 2000, 23:S101-S108.
19. Brown R.M., Crane A.M., Goldman P.S. Regional distribution of monoamines in the cerebral cortex and subcortical structures on the rhesus monkey: concentrations in vivo synthesis rates. Brain Res. 1979, 168:133-150.
20. Brozoski TJ., Brown R., Rosvold H.E., Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkeys. Science 1979, 205:929-931.
21. Buhot M.C., Martin S., Segu L. Role of serotonin in memory impairment. Ann. Med. 2000, 32:210-221.
22. Cahill, L., Prins, B., Weber, M., and McGaugh, J. L. Beta-adrenergic activation and memory for emotional events. Nature, 371, 702-704.
23. Caine E.D., Weingartner H., Ludlow C.L., Cudahy E.A., Wehry S. Qualitative analysis of scopolamine-induced amnesia. Psychopharmacology 1981, 74:74-80.
24. Camps M., Cortés R., Gueye B., Probst A., Palacios J.M. Dopamine receptors in human brain: autoradiographic distribution of D2 sites. Neuroscience 1989, 28:275-290.
25. Cassaday H.J., Mitchell S.N., Williams J.H., Gray J.A. 5,7-Dihydroxytryptamine lesions in the fornix-fimbria attenuate latent inhibition. Behav. Neural Biol. 1993, 59:194-207.
26. Clark C.R., Geffen G.M., Geffen L.B. Catecholamines and the covert orientation of attention in humans. Neuropsychologia 1989, 27:131-139.
27. Cohen R.M., Gross M., Semple W.E., Nordahl T.E., Sunderland T. The metabolic brain pattern of young subjects given scopolamine. Exp. Brain Res. 1994, 100:133-143.
28. Cools R., Stefanova E., Barker R.A., Robbins T.W., O.wen A.M. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 2002, 125:584-594.
29. Cooper J.R., Bloom F.E., Roth R.H. The Biochemical Basis of Neuropharmacology 1996, 194-225. Oxford University Press, Cambridge, MA.
30. Cortés R., Gueye B., Pazos A., Probst A., Palacios J.M. Dopamine receptors in human brain: autoradiographic distribution of D1 sites. Neuroscience 1989, 28:263-273.
31. Coull J.T. Modulation of attention by noradrenaline a2-agents varies according to arousal level. Drug News Perspect. 2001, 14:1-14.
32. Coull J.T., Jones M.E.P., Egan T., Frith C.D., Maze M. Noradrenergic á2 attetional effects vary with arousal level: modulation of the thalamic pulvinar in heatlhy humans. NeuroImage 2003, 19(1):531.
33. Coull J.T., Sahakian B.J., Middleton H.C., Young A.H., Park S.B., McShane R.H., Cowen P.J., Robbins T.W. Differential effects of clonidine, haloperidol, diazepam and tryptophan depletion on focused attention and attentional search. Psychopharmacology 1995, 121:222-230.
34. Coull J.T., Frith C.D., Dolan R.J., Frackowiak R.S., Grasby P.M. The neural correlates of the noradrenergic modulation of human attention, arousal and learning. Eur. J., Neurosci. 1997, 9:589-598.
35. Coull J.T., Frith C.D., Dolan R.J. Dissociating neuromodulatory effects of diazepam on episodic memory encoding and executive function. Psychopharmacology 1999, 145:213-222.
36. Coull J.T., Buchel C., Friston K.J., Frith C.D. Noradrenergically mediated plasticity in a human attentional neuronal network. NeuroImage 2000, 10:705-715.
37. Coull J.T., Nobre A.C., Frith C.D. The noradrenergic alpha2 agonist clonidine modulates behavioural and neuroanatomical correlates of human attentional orienting and alerting. Cereb. Cortex 2001, 11:73-84.
38. Courtney S.M., Petit L., Maisog J.M., Ungerleider L.G., Haxby J.V. An area specialised for spatial working memory in human frontal cortex. Science 1998, 279:1347-1351.
39. Curran H.V., Pooviboonsuk P., Dalton J.A., Lader M.H. Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology 1991, 135:27-36.
40. Curran H.V., Schifano F., Lader M.H. Models for memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood. Psychopharmacology 1991, 103:83-90.
41. Daniel D.G., Weinberger D.R., Jones D.W., Zigun J.R., Coppola R., Handel S., Bigelow L.B., Goldberg T.E., Berman K.F., Kleinman J.E. The effect of amphetamine on regional cerebral blood flow during cognitive activiation in schizophrenia. J. Neurosci. 1991, 11:1907-1917.
42. Davis K.L., Mohs R.C. Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine. Am. J. Psychiatry 1982, 139:1421-1424.
43. de Wit H., Metz J., Wagner N., Cooper M. Effects of diazepam on cerebral metabolism and mood in normal volunteers. Neuropsychopharmacology 1991, 5:33-41.
44. Dolan R.J., Fletcher P., Frith C.D., Friston K.J., Frackowiak R.S.J., Grasby P.M. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia. Nature 1995, 378:180-182.
45. Elliott M.A., Becker C., Boucart M., Muller H.J. Enhanced GABA(A) inhibition enhances synchrony coding in human perception. NeuroReport 2000, 11:3403-3407.
46. Ernst M., Matochik J.A., Heishman S.J., Van Horn J.D., Jons P.H., Henningfield J.E., London E.D. Effect of nicotine on brain activation during performance of a working memory task. Proc. Natl. Acad. Sci. USA 2001, 98:4728-4733.
47. Evenden J.L. Impulsivity: a discussion of clinical and experimental findings. J. Psychopharmacol. 1999, 13:180-192.
48. Fibiger H.C. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. TINS 1991, 14:220-223.
49. Fletcher P.C., Frith C.D., Grasby P.M., Friston K.J., Dolan R.J. Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia. J. Neurosci. 1996, 16:7055-7062.
50. Foote S.L., Morrison J.H. Extrathalamic modulation of cortical function. Ann. Rev., Neurosci. 1987, 19:67-95.
51. Foote S.L., Aston-Jones G., Bloom F.E. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc. Natl. Acad. Sci. USA 1975, 77:3033-3037.
52. Fredrikson M., Wik G., Annas P., Ericson K., Stone-Elander S. Functional neuroanatomy of visually elicited simple phobic fear: additional data and theoretical analysis. Psychophysiology 1995, 32:43-48.
53. Friston K.J. Functional and effective connectivity in neuroimaging: a synthesis. Hum. Brain Mapping 1994, 2:56-78.
54. Frith C.D., Richardson J.T., Samuel M., Crow T.J., McKenna P.J. The effects of intravenous diazepam and hyoscine upon human memory. Q. J. Exp. Psychol. A 1984, 36:133-144.
55. 2O PET study of the neuromodulatory effects of clonidine. Biol. Psychiatry 2001, 49:317-325.
56. Furey M.L., Pietrini P., Haxby J.V., Alexander G.E., Lee H.C., VanMeter J., Grady C.L., Shetty U., Rapoport S.I., Schapiro M.B., Freo U. Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory. Proc, Natl. Acad. Sci. USA 1997, 94:6512-6516.
57. Furey M.L., Pietrini P., Alexander G.E., Schapiro M.B., Horwitz B. Cholinergic enhancement improves performance on working memory by modulating the functional activity in distinct brain regions: a positron emission tomography regional cerebral blood flow study in healthy humans. Brain Res. Bull. 2000, 51:213-218.
58. Furey M.L., Pietrini P., Haxby J.V. Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 2000, 290:2315-2319.
59. Ghatan P.H., Ingvar M., Eriksson L., Stone-Elander S., Serrander M., Ekberg K., Wahren J. Cerebral effects of nicotine during cognition in smokers and non-smokers. Psychopharmacology 1998, 136:179-189.
60. Goldman-Rakic P.S. Circuitry of the primate prefrontal cortex and the regulation of behaviour by representational memory. Handbook of Physiology. Vol. V. The Nervous System of the Brain, Section 1, Part 1, Higher Functions of the Brain 1987, American Physiological Society, London. F. Plum (Ed.).
61. Goldman-Rakic P.S., Selemon L.D., Schwartz M.L. Dual pathways connecting the dorsolateral prefrontal cortex with the hippocampal formation and parahippocampal cortex in the rhesus monkey. Neuroscience 1984, 12:719-743.
62. Goldman-Rakic P.S., Lidow M.S., Gallager D.W. Overlap of dopaminergic, adrenergic and serotonergic receptors and complementarity of their subtypes in primate prefrontal cortex. J. Neurosci. 1990, 10:2125-2138.
63. Gower A.J. 5-HT receptors and cognitive function. Central 5-HT Receptors and Psychotropic Drugs 1992, 239-259. Blackwell Scientific, Bethesda, MD. C.A. Marsden, D.J. Heal (Eds.).
64. Grasby P.M., Friston K.J., Bench C.J., Frith C.D., Paulesu E., Cowen P.J., Liddle P.F., Frackowiak R.S.J., Dolan R. The effect of apomorphine and buspirone on regional cerebral blood flow during the performance of a cognitive task: measuring neuromodulatory effects of psychotropic drugs in man. Eur. J. Neurosci. 1992, 4:1203-1212.
65. Grasby P.M., Frith C.D., Paulesu E., Friston K.J., Frackowiak R.S., Dolan R.J. The effect of the muscarinic antagonist scopolamine on regional cerebral blood flow during the performance of a memory task. Exp. Brain Res. 1995, 104:337-348.
66. Hagan J.J. The status of the cholinergic hypothesis of dementia. Anti-Dementia Agents: Research and Prospects for Therapy 1994, 85-138. Academic Press, Oxford. C.D. Nicholson (Ed.).
67. Harrison A.A., Everitt B.J., Robbins T.W. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology 1997, 133:329-342.
68. Horwitz B., Tagamets M.A., McIntosh A.R. Neural modelling, functional brain imaging, and cognition. Trends Cogn. Sci. 1999, 3:91-98.
69. Kimberg D.Y., Aguirre G.K., Lease J., D'Esposito M. Cortical effects of bromocriptine, a D2 dopamine receptor agonist, in human subjects, revealed by fMRI. Hum. Brain Mapping 2001, 12:246-257.
70. Kinomura S., Larsson J., Gulyas B., Roland P.E. Activation by attention of the human reticular formation and thalamic intralaminar nuclei. Science 1996, 271:512-515.
71. Koepp M.J., Gunn R.N., Lawrence A.D., Cunningham V.J., Dagher A., Jones T., Brooks D.J., Bench C.J., Grasby P.M. Evidence for striatal dopamine release during a video game. Nature 1998, 393:266-268.
72. Koskinen T., Ruotsalainen S., Puumala T., Lappalainen R., Koivisto E., Mannisto P.T., Sirvio J. Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology 2000, 39:471-481.
73. Krnjevic K., Phillis J.W. Acetylcholine-sensitive cells in the cerebral cortex. J. Physiol. 1963, 166:296-327.
74. Lawrence N.S., Ross T.J., Stein E.A. Cognitive mechanisms of nicotine on visual attention. Neuron 2002, 36:348-539.
75. Legrand F., Vidailhet P., Danion J.M., Grange D., Giersch A., van der Linden M., Imbs J.L. Time course of the effects of diazepam and lorazepam on perceptual priming and explicit memory. Psychopharmacology 1995, 118:475-479.
76. Levin E.D. Nicotinic systems and cognitive function. Psychopharmacology 1992, 108:417-431.
77. Levitt P., Rakic P., Goldman-Rakic P.S. Region-specific distribution of catecholamine afferents in primate cerebral cortex: a fluorescence histochemical analysis. J. Comp. Neurol. 1984, 227:23-36.
78. Linnoila M., Virkkunen M., Scheinin M., Nuutila A., Rimon R., Goodwin F.K. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behaviour. Life Sci. 1983, 33:2609-2614.
79. Little J.T., Johnson D.N., Minichiello M., Weingartner H., Sunderland T. Combined nicotinic and muscarinic blockade in elderly normal volunteers: cognitive, behavioural, and physiologic responses. Neuropsychopharmacology 1998, 19:60-69.
80. Loubinoux I., Pariente J., Boulanouar K., Carel C., Manelfe C., Rascol O., Celsis P., Chollet F. A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects. NeuroImage 2002, 15:26-36.
81. Luciana M., Depue R.A., Arbisi P., Leon A. Facilitation of working memory in humans by a D2 dopamine receptor agonist. J. Cogn. Neurosci. 1992, 4:58-68.
82. Mattay V.S., Berman K.F., Ostrem J.L., Esposito G., Van Horn J.D., Bigelow L.B., Weinberger D.R. Dextroamphetamine enhances 'neural-network-specific' physiological signals: a positron emission tomography rCBF study. J., Neurosci. 1996, 16:4816-4822.
83. Mattay V.S., Callicott J.H., Bertolino A., Heaton I., Frank J.A., Coppola R., Berman KF., Goldberg T.E., Weinberger D.R. Effects of dextroamphetamine on cognitive performance and cortical activation. NeuroImage 2000, 12:268-275.
84. Mattay V.S., Tessitore A., Callicott J.H., Bertolino A., Goldberg T.E., Chase T.N., Hyde T.M., Weinberger D.R. Dopaminergic modulation of cortical function in patients with, Parkinson's disease. Ann. Neurol. 2002, 51:156-164.
85. McEntee W.J., Crook T.H. Serotonin, memory, and the aging brain. Psychopharmacology 1991, 103:143-149.
86. A-receptor subtypes really occur in the brain? [see comments]. Trends Neurosci. 1996, 19:139-143.
87. Mehta M.A., Owen A.M., Sahakian B.J., Mavaddat N., Pickard J.D., Robbins T.W. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J. Neurosci. 2000, 20:R651-R656.
88. Meneses A. 5-HT system and cognition. Neurosci. Biobehav. Rev. 1999, 23:1111-1125.
89. Mentis M.J., Sunderland T., Lai J., Connolly C., Krasuski J., Levine B., Friz J., Sobti S., Schapiro M., Rapoport S.I. Muscarinic versus nicotinic modulation of a visual task: a pet study using drug probes. Neuropsychopharmacology 2001, 25:555-564.
90. Metherate R., Ashe J.H. Basal forebrain stimulation modifies auditory cortex responsiveness by an action at muscarinic receptors. Brain Res. 1991, 559:163-167.
91. Mintzer M.Z., Griffiths R.R., Contoreggi C., Kimes A.S., London E.D., Ernst M. Effects of triazolam on brain activity during episodic memory encoding: a PET study. Neuropsychopharmacology 2001, 25:744-756.
92. Molchan S.E., Martinez R.A., Hill J.L., Weingartner H.J., Thompson K., Vitiello B., Sunderland T. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model. Brain Res. Rev. 1992, 17:215-226.
93. Molchan S.E., Sunderland T., McIntosh A.R., Herscovitch P., Schreurs B.G. A functional anatomical study of associative learning in humans. Proc. Natl. Acad. Sci. USA 1994, 91:8122-8126.
94. Morris J.S., Smith K.A., Cowen P.J., Friston K.J., Dolan R.J. Covariation of activity in habenula and dorsal raphe nuclei following tryptophan depletion. NeuroImage 1999, 10:163-172.
95. Müller U., von Cramon D.Y., Pollmann S. D1 versus D2 receptor modulation of visuospatial working memory in humans. J. Neurosci. 1998, 18:2720-2728.
96. Nissen M.J., Knopman D.S., Schacter D.L. Neurochemical dissociation of memory systems. Neurology 1987, 37:789-794.
97. Nordberg A. In vivo detection of neurotransmitter changes in Alzheimer's disease. Ann. N.Y. Acad. Sci. 1993, 695:27-33.
98. Nordberg A. PET studies and cholinergic therapy in Alzheimer's disease. Rev. Neurol. 1999, 155(Suppl 4):S53-S63.
99. Nordberg A., Nilsson-Hakansson L., Adem A., Lai Z., Winblad B. Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains. Prog. Clin. Biol. Res. 1989, 317:1169-1178.
100. Northoff G., Witzel T., Richter A., Gessner M., Schlagenhauf F., Fell J., Baumgart F., Kaulisch T., Tempelmann C., Heinzel A., Kotter R., Hagner T., Bargel B., Hinrichs H., Bogerts B., Scheich H., Heinze H.J. GABA-ergic modulation of prefrontal spatio-temporal activation pattern during emotional processing: a combined fMRI/MEG study with placebo and lorazepam. J. Cogn, Neurosci. 2002, 14:348-370.
101. Nutt D.J., Malizia A.L. New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. Br. J. Psychiatry 2001, 179:390-396.
102. Ordway G.A., Widdowson P.S., Smith K.S., Halaris A. Agonist binding to alpha-2 adrenoceptors is elevated in the locus coeruleus from victims of suicide. J. Neurochem. 1994, 63:617-624.
103. Ouchi Y., Yoshikawa E., Futatsubashi M.O., Kada H., Torizuka T., Sakamoto M. Effect of simple motor performance on regional dopamine release in the striatum in Parkinson's disease patients and healthy subjects: a positron emission tomography study. J. Cereb. Blood Flow Metab. 2002, 22:746-752.
104. Park S.B., Coull J.T., McShane R.H., Young A.H., Sahakian B.J., Robbins T.W., Cowen PJ Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology 1994, 33:575-588.
105. Parnetti L., Senin U., Mecocci P. Cognitive enhancement therapy for Alzheimer's disease: the way forward. Drugs 1997, 53:752-768.
106. Passingham R. The frontal Lobes and Voluntary Action 1993, 103-123. Oxford University Press, London.
107. Paul S.E. GABA and glycine. Psychopharmacology: The Fourth Generation of Progress 1995, Raven Press, London. F.E. Bloom, D.J. Kupfer (Eds.).
108. Perry E.K., Blessed G., Tomlinson B.E., Perry R.H., Crow T.J., Cross A.J., Dockray G.J., Dimaline R., Arregui A. Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes. Neurobiol. Aging 1981, 2:251-256.
109. Portas C.M., Rees G., Howseman A.M., Josephs O., Turner R., Frith C.D. A. specific role for the thalamus in mediating the interaction of attention and arousal in humans. J. Neurosci. 1998, 18:8979-8989.
110. Rajkowski J., Kubiak P., Ivanova S., Aston-Jones G. State-related activity, reactivity of locus coeruleus neurons in behaving monkeys. Adv. Pharmacol. 1998, 42:740-744.
111. Rasmusson D.D. The role of acetylcholine in cortical synaptic plasticity. Behav. Brain Res. 2000, 115:205-218.
112. Riedel W.J., Klaassen T., Deutz N.E., van Someren A., van Praag H.M. Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology 1999, 141:362-369.
113. Robbins T.W., Everitt B.J. Functions of dopamine in the dorsal and ventral striatum. Semin. Neurosci. 1992, 4:119-127.
114. Roberts A.C., De Salvia M.A., Wilkinson L.S., Collins P., Muir J.L., Robbins T.W. 6-Hydroxy-dopamine lesions of the prefrontal cortex in monkeys enhance performance on an analogue of the Wisconson card sort, test: possible interactions with subcortical dopamine. J. Neurosci. 1994, 14:2531-2544.
115. Rogers R.D., Blackshaw A.J., Middleton H.C., Matthews K., Hawtin K., Crowley C., Wallace C., Deakin J.F., Sahakian B.J., Robbins T.W. Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour. Psychopharmacology 1999, 146:482-491.
116. Rosier A.M., Cornette L., Dupont P., Bormans G., Michiels J., Mortelmans L., Orban G.A. Positron-emission tomography imaging of long-term shape recognition challenges. Proc. Natl. Acad. Sci. USA 1997, 94:7627-7632.
117. Rosier A.M., Cornette L., Dupont P., Bormans G., Mortelmans L., Orban G.A. Regional brain activity during shape recognition impaired by a scopolamine challenge to encoding. Eur. J., Neurosci. 1999, 11:3701-3714.
118. Rosse R.B., Schwartz B.L., Zlotolow S.R.D., Banay-Schwartz M., Trinidad A.C., Peace T.D., Deutsch S.I. Effect of a low-tryptophan diet as an adjuvant to conventional neuroleptic therapy in schizophrenia. Clin. Neuropharmacol. 1992, 15:129-141.
119. Rowe J.B., Toni I., Josephs O., Frackowiak R.S.J., Passingham R.E. The prefrontal cortex: response selection or maintenance within working memory?. Science 2000, 288:1556-1560.
120. Rubinsztein J.S., Rogers R.D., Riedel W.J., Mehta M.A., Robbins T.W., Sahakian B.J. Acute dietary tryptophan depletion impairs maintenance of 'affective set' and delayed visual recognition in healthy volunteers. Psychopharmacology 2001, 154:319-326.
121. Rusted J.M., Warburton D.M. The effects of scopolamine on working memory in healthy young volunteers. Psychoparmacology 1988, 96:145-152.
122. Sarter M. Neural mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin?. Psychopharmacology 1994, 114:539-550.
123. Sarter M., Bruno J.P. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res. Rev. 1997, 23:28-46.
124. Sato H., Hata Y., Masui H., Tsumoto T. A. functional role of cholinergic innervation to neurons in the cat visual cortex. J. Neurophysiol. 1987, 58:765-780.
125. Sato H., Hata Y., Masui H., Tsumoto T. A. functional role of cholinergic innervation to neurons in the cat visual cortex. J. Neurophysiol. 1987, 58:765-780.
126. Sawaguchi T., Goldman-Rakic P.S. The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J. Neurophysiol. 1994, 71:515-528.
127. Schmitt J.A., Jorissen B.L., Sobczak S., van Boxtel M.P., Hogervorst E., Deutz N.E., Riedel W.J. Tryptophan depletion impairs memory consolidation but improves focused attention in healthy young volunteers. J. Psychopharmacol. 2000, 14:21-29.
128. Schreurs B.G., McIntosh A.R., Bahro M., Herscovitch P., Sunderland T., Molchan S.E. Lateralisation and behavioural correlation of changes in regional cerebral blood flow with classical conditioning of the human eyeblink response. J. Neurophysiol. 1997, 77:2153-2163.
129. Schultz W. Dopamine neurons and their role in reward mechanisms. Curr. Opin. Neurobiol. 1997, 7:191-197.
130. Schultz W., Apicella P., Ljungberg T. Responses of monkey dopamine neurones to reward and conditioned stimuli during successive steps of learning a delayed response task. J. Neurosci. 1993, 13:900-913.
131. Segal M., Bloom F.E. The action of norepinephrine in the rat hippocampus. IV. The effects of locus coeruleus stimulation on evoked hippocampal unit activity. Brain Res. 1976, 107:513-525.
132. Smith A.P., Nutt D. Noradrenaline and attention lapses. Nature 1996, 380:291.
133. Smith A.P., Wilson S.J., Glue P., Nutt D.J. The effects and after effects of the a2-adrenoceptor antagonist idazoxan on mood, memory and attention in normal volunteers. J. Psychopharmacol. 1992, 6:376-381.
134. Smith E.E., Jonides J. Neuroimaging analyses of human working memory. Proc. Natl. Acad. Sci. USA 1998, 95:12061-12068.
135. Sperling R., Greve D., Dale A., Killiany R., Holmes J., Rosas H.D., Cocchiarella A., Firth P., Rosen B., Lake S., Lange N., Routledge C., Albert M. Functional, MRI detection of pharmacologically induced memory impairment. Proc. Natl. Acad. Sci. USA 2002, 99:455-460.
136. Stegeren A.H., Everaerd W., Cahill L., McGaugh J.L., Gooren L.J. Memory for emotional events: differential effects of centrally versus peripherally acting beta-blocking agents. Psychopharmacology 1998, 138:305-310.
137. Swartz B.E., Kovalik E., Thomas K., Torgersen D., Mandelkern M.A. The effects of an alpha-2 adrenergic agonist, guanfacine, on rCBF in human cortex in normal controls and subjects with focal epilepsy. Neuropsychopharmacology 2000, 23:263-275.
138. Thiel C.M., Henson R.A., Morris J.S., Friston K.J., Dolan R.J. Pharmacological modulation of behavioural and neuronal correlates of repetition priming. J. Neurosci. 2001, 21:6846-6852.
139. Thiel C.M., Friston K.J., Dolan R.J. Cholinergic modulation of experience-dependent plasticity in human auditory cortex. Neuron 2002, 35:567-574.
140. Thiel C.M., Henson R.N.A., Dolan R.J. Scopolamine but not lorazepam impairs face repetition priming: a psychopharmacological fMRI study. Neuropsychopharmacology 2002, 27:282-292.
141. Thiel C.M., Bentley P., Dolan R.J. Effects of cholinergic enhancement on conditioning-related responses in human auditory cortex. Eur. J. Neurosci. 2002, 16:2199-2206.
142. Thobois S., Guillouet S., Brouselle E. Contributions of, PET and SPECT to the understanding of the pathophysiology of, Parkinson's Disease. Neurophysiol. Clin. 2001, 31:321-340.
143. Tremblay N., Warren R.A., Dykes R.W. Electrophysiological studies of acetylcholine and the role of the basal forebrain in the somatosensory cortex of the cat. II. Cortical neurons excited by somatic stimuli. J. Neurophysiol. 1990, 64:1212-1222.
144. Ungerstedt U. Stereotaxic mapping of the momoamine pathways in the rat brain. Acta Phys. Scand. 1971, 367:1-49. (suppl.).
145. Vitiello B., Martin A., Hill J., Mack C., Molchan S., Martinez R., Murphy D.L., Sunderland T. Cognitive and behavioural effects of cholinergic, dopaminergic, and serotonergic blockade in humans. Neuropsychopharmacology 1997, 16:15-24.
146. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Jayne M., Franceschi D., Wong C., Gatley S.J., Gifford A.N., Ding Y.S., Pappas N. 'Nonhedonic' food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse 2002, 44:175-180.
147. Wagemans J., Notebaert W., Boucart M. Lorazepam but not diazepam impairs identification of pictures on the basis of specific contour fragments. Psychopharmacology 1998, 138:326-333.
148. Weinberger N.M. Learning-induced receptive field plasticity in the primary auditory cortex. Semin. Neurosci. 1997, 9:59-67.
149. Wesnes K., Warburton D.M. Effects of scopolamine and nicotine on human rapid information processing performance. Psychoparmacologia 1984, 82:147-150.
150. Williams G.V., Goldman-Rakic P.S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 1995, 376:572-575.
151. Zald D.H., El-Deredy W., Boileau I., Gunn R., McGlone F., Dichter G., Dagher A. Measurement of dopamine release during expecetd and unexpected reward. paper presented at the NeuroImage Human Brain Mapping 2002 meeting 2002.
152. Zilles K., Palomero-Gallagher N. Cyto-, myelo-, and receptor architectonics of the human parietal cortex. NeuroImage. 2001, 14:S8-S20.
153. Zilles K., Schleicher A., Palomero-Gallagher N., Amunts K. Quantitative analysis of cyto- and receptorarchitecture of the human brain. Brain Mapping: The Methods 2002, Academic Press, New York. A.W. Toga, J.C. Mazziotta (Eds.).